Gosset research
Reports: Report, Immunology
Gosset reports matching these filters, newest first.
2 items Clear filters
Report
HCXT-2001: oral IL-23R inhibition
Inside the oral IL-23R program behind Gilead’s announced acquisition agreement: mechanism, clinical evidence and competition.
- External sample
Report · External · Google Sheets
Head-to-head results: IL-13 vs IL-4Rα biologics in atopic dermatitis (EASI-75, IGA 0/1) (opens Google Sheets on Google Drive)
Side-by-side comparison of trial outcomes for a drug class or indication. Covers safety, efficacy, patient population, and trial design.